Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
FAM105B Promotes Hepatocellular Carcinoma Progression and Metastasis by Activating the PI3K/AKT/MTOR Signaling
Liu-Lin Yang1, Xing Chen2, Shao-Tong Tang1
1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Background:
Recurrence and metastasis are major contributors to poor prognosis in hepatocellular carcinoma (HCC), yet the mechanisms remain unclear. FAM105B, a specific deubiquitinating enzyme, is critical in various biological processes, including cancer progression. However, its role in HCC is not well understood.
Methods:
FAM105B expression in HCC patients was validated using public clinical datasets. Cox regression and Kaplan-Meier analyses assessed its association with clinicopathological features and prognosis. In vitro and in vivo experiments evaluated the effects of FAM105B on HCC cell proliferation and invasion. Its role in epithelial-mesenchymal transition (EMT) and the PI3K/AKT/MTOR pathway was analyzed via, Western blot, Reverse Transcription Quantitative Polymerase Chain Reaction (qRT-PCR), immunohistochemistry and immunofluorescence.
Results:
FAM105B was significantly upregulated in HCC tissues and cell lines. High FAM105B expression correlated with aggressive features and poorer overall survival (OS) and disease-free survival (DFS). Functional studies revealed that FAM105B overexpression promoted, while knockdown inhibited, HCC cell proliferation and invasion. Mechanistically, FAM105B induced EMT and activated the PI3K/AKT/MTOR pathway.
Conclusion:
FAM105B promotes HCC progression by inducing EMT and activating the PI3K/AKT/MTOR pathway, highlighting its potential as a therapeutic target and prognostic biomarker.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades